Acutaas Chemicals Limited (NSE:ACUTAAS)
India · Delayed Price · Currency is INR 3,994.80
+77.90 (1.99%)
Nov 12, 2026, 3:10 PM IST
Acutaas Chemicals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 327,059 | 209,475 | 99,913 | 40,336 | 32,418 | 36,519 | |
Market Cap Growth | 126.41% | 109.66% | 147.70% | 24.43% | -11.23% | - |
Enterprise Value | 324,771 | 207,407 | 97,277 | 40,451 | 31,894 | 35,609 |
Last Close Price | 3916.90 | 2556.69 | 1218.25 | 544.76 | 442.13 | 496.61 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 74.83 | 58.80 | 62.95 | 94.30 | 38.92 | 50.76 |
Forward PE | 56.65 | 57.40 | 51.29 | 39.61 | 29.51 | 40.59 |
PS Ratio | 20.11 | 15.64 | 9.92 | 5.62 | 5.26 | 7.02 |
PB Ratio | 16.68 | 12.25 | 7.57 | 5.91 | 5.46 | 6.99 |
P/TBV Ratio | 18.33 | 13.58 | 8.03 | 6.65 | 5.87 | 7.39 |
P/OCF Ratio | 86.19 | 71.70 | 84.43 | 32.23 | 49.47 | - |
PEG Ratio | 1.79 | 1.33 | 0.76 | 2.66 | 0.93 | 1.27 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 19.97 | 15.49 | 9.66 | 5.64 | 5.17 | 6.85 |
EV/EBITDA Ratio | 50.99 | 43.23 | 42.04 | 31.65 | 25.95 | 34.04 |
EV/EBIT Ratio | 54.65 | 46.61 | 47.35 | 35.98 | 28.73 | 37.45 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | 0.32 | 0.01 | 0.00 |
Debt / EBITDA Ratio | 0.02 | 0.07 | 0.06 | 1.69 | 0.03 | 0.01 |
Debt / FCF Ratio | 0.25 | - | - | - | - | - |
Net Debt / Equity Ratio | -0.15 | -0.11 | -0.18 | 0.24 | -0.09 | -0.19 |
Net Debt / EBITDA Ratio | -0.47 | -0.39 | -1.02 | 1.28 | -0.45 | -0.94 |
Net Debt / FCF Ratio | -4.79 | 5.29 | 3.09 | -0.86 | 4.30 | 2.16 |
Asset Turnover | 0.81 | 0.76 | 0.76 | 0.77 | 0.87 | 0.97 |
Inventory Turnover | 2.77 | 2.83 | 3.34 | 3.02 | 2.90 | 3.20 |
Quick Ratio | 2.63 | 2.55 | 2.67 | 0.92 | 1.82 | 2.15 |
Current Ratio | 3.99 | 3.82 | 3.91 | 1.73 | 2.81 | 3.32 |
Return on Equity (ROE) | 26.11% | 23.52% | 16.02% | 7.63% | 14.92% | 20.88% |
Return on Assets (ROA) | 18.57% | 15.74% | 9.71% | 7.54% | 9.73% | 11.09% |
Return on Invested Capital (ROIC) | 27.02% | 25.21% | 15.80% | 9.66% | 17.13% | 20.65% |
Return on Capital Employed (ROCE) | 29.60% | 25.40% | 15.30% | 13.90% | 18.40% | 18.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.34% | 1.70% | 1.59% | 1.06% | 2.57% | 1.97% |
FCF Yield | 0.19% | -0.17% | -0.76% | -4.70% | -0.40% | -1.25% |
Dividend Yield | 0.06% | 0.10% | 0.12% | 0.55% | 0.34% | 0.30% |
Payout Ratio | 7.46% | 3.45% | 7.74% | 25.56% | 13.13% | - |
Buyback Yield / Dilution | -0.55% | -2.51% | -9.26% | -0.63% | -6.53% | -8.59% |
Total Shareholder Return | -0.49% | -2.41% | -9.14% | -0.08% | -6.19% | -8.29% |